Patents Represented by Attorney Sandra Rueck

Find this attorney in the Justia Lawyer Directory

  • 1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors
    Patent number: 7994170
    Abstract: The invention relates to novel organic compounds of formula (I) processes for the preparation thereof, the application thereof in a process for the treatment of the human or animal body, the use thereof—alone or in combination with one or more other pharmaceutically active compounds—for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders commonly occurring in connection with transplantation, or a proliferative disease, such as a tumor disease.
    Type: Grant
    Filed: October 12, 2009
    Date of Patent: August 9, 2011
    Assignee: Novartis AG
    Inventors: Carlos Garcia-Echeverria, Frédéric Stauffer, Pascal Furet